Technician I, Fractionation jobs in United States
cer-icon
Apply on Employer Site
company-logo

ADMA Biologics, Inc. · 3 months ago

Technician I, Fractionation

ADMA Biologics is a biopharmaceutical company committed to creating superior products for immunodeficient patients at risk for infection. They are seeking a Technician I, Fractionation to assist in the manufacturing of plasma products, focusing on cleaning, sanitizing, and preparing equipment and solutions.

BiotechnologyHealth CareManufacturingMedical
badNo H1Bnote

Responsibilities

Cleans and Sanitizes Equipment before and after use
Cleans and Sanitizes Manufacturing Areas daily
Operates COP washer
Receives and de-boxes plasma units
Operates plasma bottle cutter
Operates pooling tank lift
Set up and harvest centrifuges
Monitors centrifuge flow and temperatures
Prepares buffer solutions
Removes trash (empty plasma bottles, etc) from the TCP and Fractionation areas
Maintains stock of gowning supplies
Make connections on flow panels for product transfers
Follow manufacturing SOP’s and Batch Records
Additional tasks associated with advancement to the Tech II position

Qualification

CGMP complianceBuffer preparationCentrifuge operationGMP experienceAttention to detail

Required

High School Diploma or GED
Ability to follow the cGMP's and procedures with great attention to detail

Preferred

Associate degree or equivalent experience preferred
GMP experience preferred

Benefits

401K plan with employer match and immediate vesting
Medical, Vision, Life and Dental Insurance
Pet Insurance
Company paid STD and LTD
Company Paid Holidays
3 Weeks’ Paid Time Off (within the first year)
Tuition Assistance (after the first year)
Easily accessible to Tri-Rail
Free shuttle to the Boca Tri-Rail station

Company

ADMA Biologics, Inc.

twittertwitter
company-logo
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.

Funding

Current Stage
Public Company
Total Funding
$1.04B
Key Investors
JP MorganAres ManagementHayfin Capital Management
2025-08-06Post Ipo Debt· $300M
2023-12-18Post Ipo Debt· $135M
2022-12-07Post Ipo Equity· $60M

Leadership Team

leader-logo
Adam Grossman
Founder, President & CEO
linkedin
Company data provided by crunchbase